The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06241066

Enrollment

359

Registered

2024-02-05

Start date

2014-01-01

Completion date

2023-10-31

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Squamous Cell Carcinoma

Brief summary

Retrospective analysis of the presence and maturity of tertiary lymphoid structures in pathological sections of patients with esophageal squamous cell carcinoma after surgical treatment. Pay attention to the overall survival and disease free survival of these esophageal squamous cell carcinoma patients.

Interventions

OTHERno-Intervention

no-Intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* 1\. Pathologically diagnosed as esophageal squamous cell carcinoma; 2. Surgery for esophageal cancer; 3. Complete medical records;

Exclusion criteria

* Patients with a previous history of malignant tumor

Design outcomes

Primary

Measure	Time frame	Description
OS	The time from treatment to death or last follow-up, assessed up to 100 months.	Overall Survival
DFS	The time from treatment to the first recurrence or last follow-up, assessed up to 100 months.	Disease-free Survival

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026